Investors
U.S. FDA Development of Non-Traditional Therapies for Bacterial Infections Panel
The Food and Drug Administration held a public workshop entitled “Development of Non-Traditional Therapies for Bacterial Infections." Aridis Pharmaceuticals Founder and Chief Executive Officer Vu Truong served as an expert panel member at the workshop.
The purpose of the public workshop was to discuss the general development considerations of non-traditional therapies, including pre-clinical development, early clinical studies, and phase 3 clinical trial designs to evaluate safety and efficacy.